Series B · Biotech · Paris, France · Founded 2019 · 11–50 employees
WhiteLab Genomics is a Paris-based company founded in 2019, specializing in AI-driven solutions to accelerate the development of genomic medicines, including gene and cell therapies. By leveraging proprietary technology, they analyze complex biological data to optimize therapeutic design, aiming to reduce development timelines and costs. Recognized for their contributions, they are part of the French Tech 2030 program and have established strategic partnerships with industry leaders like Sanofi and Debiopharm.
No open roles listed right now.